Academia.eduAcademia.edu

Ethanolamine Utilization

description6 papers
group1 follower
lightbulbAbout this topic
Ethanolamine utilization refers to the biochemical processes and applications involving ethanolamine, an organic compound that serves as a building block for phospholipids and is involved in various metabolic pathways. This field encompasses its role in cellular functions, industrial applications, and potential therapeutic uses.
lightbulbAbout this topic
Ethanolamine utilization refers to the biochemical processes and applications involving ethanolamine, an organic compound that serves as a building block for phospholipids and is involved in various metabolic pathways. This field encompasses its role in cellular functions, industrial applications, and potential therapeutic uses.

Key research themes

1. How do bacterial microcompartments and extracellular electron transfer systems facilitate anaerobic ethanolamine utilization in pathogens?

This research theme focuses on the molecular and physiological mechanisms by which bacteria, particularly human pathogens like Listeria monocytogenes, utilize ethanolamine (EA) under anaerobic conditions. The investigation centers on the role of bacterial microcompartments (BMCs) that encapsulate ethanolamine catabolic enzymes and the involvement of extracellular electron transfer (EET) systems, particularly flavin-based EET, in maintaining redox balance and supporting growth. These mechanisms are critical for pathogen survival and virulence in nutrient-limited and anaerobic environments such as the human gastrointestinal tract, making them of interest for understanding bacterial metabolism and potential therapeutic targeting.

Key finding: The study demonstrated that Listeria monocytogenes forms ethanolamine-utilizing bacterial microcompartments (eut BMCs) under anaerobic conditions, converting EA predominantly into acetate and ethanol in a 2:1 molar ratio.... Read more

2. What is the role of acetaldehyde metabolism and aldehyde dehydrogenase (ALDH2) activation in modulating ethanol intake and its neurobehavioral effects?

This theme investigates the metabolic and neuropharmacological contributions of acetaldehyde, the primary ethanol metabolite, in modulating ethanol's reinforcing properties, intake behavior, and toxicity. It particularly emphasizes the role of aldehyde dehydrogenase-2 (ALDH2) in acetaldehyde catabolism within the central nervous system, exploring pharmacological activation of ALDH2 as a strategy to attenuate ethanol intake. Understanding these metabolic pathways is essential for developing treatments for alcohol use disorders by targeting acetaldehyde bioavailability and its neurobehavioral effects.

Key finding: This study established that systemic administration of ALDA-1, an activator of mitochondrial ALDH2, significantly enhanced brain ALDH2 enzymatic activity threefold, which led to a pronounced reduction in the acquisition of... Read more
Key finding: This comprehensive review synthesizes decades of research on acetaldehyde’s central and peripheral effects, highlighting its reinforcing properties independent of ethanol itself. It underscores behavioral and pharmacological... Read more
Key finding: Using in vivo microdialysis in rat nucleus accumbens, this study showed that direct local ethanol perfusion raised extracellular dopamine levels; however, neither local administration of acetaldehyde nor systemic... Read more

3. How can modulation of glutamatergic and monoaminergic transporter systems influence ethanol self-administration and potential treatment strategies for alcohol use disorder?

This line of research examines the neurochemical mechanisms underlying ethanol intake, focusing on the role of transporter proteins such as organic cation transporter 3 (OCT3) and the cystine-glutamate antiporter (system x_c−). It evaluates how ethanol affects monoamine uptake via these transporters, influences glutamate homeostasis, and how pharmacological modulation (e.g., N-acetylcysteine) affects ethanol-related behaviors. These insights inform development of novel pharmacotherapeutics targeting transporter systems to reduce ethanol self-administration and relapse in alcohol use disorder.

Key finding: This study revealed that ethanol inhibits monoamine uptake not via classical transporters (DAT, NET, SERT) but selectively through organic cation transporter 3 (OCT3). Using OCT3 knockout mice and in vivo electrochemical... Read more
Key finding: Chronic intermittent ethanol vapor exposure established dependence in rats, which showed elevated ethanol self-administration, seeking, motivation, and relapse. Administration of N-acetylcysteine (NAC) at low doses... Read more

All papers in Ethanolamine Utilization

The Escherichia coli genes pta and eutD encode proteins containing the phosphate-acetyltransferase domain. EutD is composed only by this domain and belongs to the ethanolamine operon. This enzyme has not been characterized yet, and its... more
Download research papers for free!